In a significant market transaction on Friday, 98.65 lakh shares of Jubilant Ingrevia Ltd were exchanged via a block deal, amounting to a total value of ₹666.88 crore. The shares were traded at ₹676 apiece, reflecting a slight discount to the previous close of ₹682.
This comes as part of the broader promoter stake sale by the Bhartia family, who are offloading shares across multiple listed group companies — Jubilant Ingrevia, Jubilant FoodWorks, and Jubilant Pharmova — as reported earlier by CNBC-TV18.
According to sources familiar with the development, the Bhartia family was expected to sell up to 1.2 crore shares in Jubilant Ingrevia through block deals. The sale is being facilitated by Morgan Stanley, acting as the broker for the transaction.
Jubilant Ingrevia operates in the life sciences ingredients and specialty chemicals space, offering integrated solutions across nutrition, health, and industrial chemical domains. The company has been focused on strengthening its global footprint and product innovation pipeline.
The block deal, along with similar transactions in other group firms, is seen as a strategic financial move to realign holdings or potentially fund new business initiatives across the broader Jubilant Bhartia Group.